Investors & Media

Investor FAQs

Investor FAQs

Show All
Show all
Sage Therapeutics is headquartered at 215 First Street, Cambridge, MA 02142. The main phone number is 617-299-8380.
Sage was incorporated in 2010 in the state of Delaware.
Sage Therapeutics is traded on the NASDAQ Global Market under the ticker symbol SAGE and its CUSIP number is 78667J 108.
Sage Therapeutics’ initial public offering (IPO) occurred on July 18, 2014.
December 31st.

P.O. Box 505000
Louisville, KY 40233

Sage Therapeutics does not have a direct stock purchase plan. Shares can be purchased through a stockbroker of your choice.

PricewaterhouseCoopers LLP
101 Seaport Boulevard, Suite 500
Boston, MA 02110
(617) 530-5000

The Sage Therapeutics press release archives can be accessed at

The Sage Therapeutics SEC filings can be accessed at or

Investor questions and inquiries can be submitted to the Sage Therapeutics investor relations department by contacting or 617-299-8380.